Myogen Heart Drug Gets FDA Fast-Track (AP via Yahoo! Finance)
Shares of Myogen Inc. continued to bleed on Thursday even after the biotech said its blood pressure treatment ambrisentan was given a fast-track designation by the Food and Drug Administration.